Reduced Intensity Fludarabine/Melphalan Has Similar Survival to Myeloablative Fludarabine/Busulfan (Targeted) in Patients with AML and MDS

Authors :: Elizabeth DiMaggio
Asmita Mishra
Brian C. Betts
Farhad Khimani
Taiga Nishihori
Braydon Schaible
Rebecca Tombleson
Zhenjun Ma
Lia Perez
Hugo F. Fernandez
Joseph Pidala
Ernesto Ayala
Claudio Anasetti
Source :: Biology of Blood and Marrow Transplantation. 23:S290
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
business.industry
Fludarabine/Melphalan
Reduced intensity
Hematology
Fludarabine
Internal medicine
medicine
In patient
business
Busulfan
medicine.drug

Full Text Access

Tools